Characteristics of Patients With Ulcerative Colitis Initiating Vedolizumab Therapy in Real-World Clinical Practice

被引：0
|
作者：
Khalid, Javaria M. [1 ]
Reynolds, Matthew [2 ]
Alam, Naufi L. [3 ]
Don, O'Hara [2 ]
Smyth, Michael D. L. [1 ]
机构：
[1] Takeda Dev Ctr Europe Ltd, London, England
[2] Evidera, Lexington, MA USA
[3] Evidera, London, England
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2015年 / 110卷
关键词：
D O I：
10.14309/00000434-201510001-01946
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1946
引用
收藏
页码：S825 / S825
页数：1
相关论文
共 50 条
  • [41] Corticosteroid Use in Patients with Crohn's Disease Initiating Vedolizumab in the Real-World Setting
    Sands, Bruce
    Khalid, Javaria
    Barocas, Morris
    Raluy-Callado, Mireia
    Merinopoulou, Evie
    INFLAMMATORY BOWEL DISEASES, 2017, 23 : S26 - S26
  • [42] Efficacy and Predictors of Outcomes of Vedolizumab for Ulcerative Colitis in Clinical Practice
    Peerani, Farhad
    Narula, Neeraj
    Dulai, Parambir S.
    Chaudrey, Khadija
    Whitehead, Diana
    Hudesman, David
    Shmidt, Eugenia
    Lukin, Dana J.
    Swaminath, Arun
    Nghia Nguyen
    Meserve, Joseph
    Kane, Sunanda V.
    Sandborn, William
    Sands, Bruce E.
    Colombel, Jean-Frederic
    Siegel, Corey A.
    Loftus, Edward V.
    Singh, Siddharth
    Boland, Brigid S.
    GASTROENTEROLOGY, 2016, 150 (04) : S392 - S393
  • [43] REAL-WORLD EFFECTIVENESS OF USTEKINUMAB IN ULCERATIVE COLITIS
    Hong, Simon
    Zullow, Samantha
    Axelrad, Jordan
    Chang, Shannon
    Hudesman, David
    INFLAMMATORY BOWEL DISEASES, 2020, 26 : S73 - S74
  • [44] REAL-WORLD EFFECTIVENESS OF USTEKINUMAB IN ULCERATIVE COLITIS
    Hong, Simon
    Zullow, Samantha
    Axelrad, Jordan
    Chang, Shannon
    Hudesman, David
    GASTROENTEROLOGY, 2020, 158 (03) : S120 - S120
  • [45] Effectiveness and safety of vedolizumab for ulcerative colitis: a single-center retrospective real-world study in China
    Huang, Kaituo
    Liu, Jing
    Xia, Wenhao
    Tian, Chuwen
    Yao, Lingya
    Cao, Qian
    Chen, Haotian
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [46] Real-World Efficacy and Safety Monitoring for Predicting Continuation of Tofacitinib Therapy in Patients with Ulcerative Colitis
    Ishida, Natsuki
    Miyazu, Takahiro
    Tamura, Satoshi
    Tani, Shinya
    Yamade, Mihoko
    Iwaizumi, Moriya
    Hamaya, Yasushi
    Osawa, Satoshi
    Furuta, Takahisa
    Sugimoto, Ken
    DIGESTIVE DISEASES AND SCIENCES, 2022, 67 (08) : 3984 - 3992
  • [47] Upadacitinib for rescue therapy in patients with acute severe ulcerative colitis: An Australian real-world experience
    Tan, W. L.
    Gilmore, R.
    Huang, A.
    Fernandes, R.
    An, Y-K
    Begun, J.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2023, 38 : 182 - 182
  • [48] Real-World Efficacy and Safety Monitoring for Predicting Continuation of Tofacitinib Therapy in Patients with Ulcerative Colitis
    Natsuki Ishida
    Takahiro Miyazu
    Satoshi Tamura
    Shinya Tani
    Mihoko Yamade
    Moriya Iwaizumi
    Yasushi Hamaya
    Satoshi Osawa
    Takahisa Furuta
    Ken Sugimoto
    Digestive Diseases and Sciences, 2022, 67 : 3984 - 3992
  • [49] Clinical Effectiveness and Safety of Vedolizumab vs. Infliximab in Biologic-Naive Ulcerative Colitis Patients: A Brazilian Real-World Multicentric Observational Study
    Ferreira, S.
    Chebli, J. M. F.
    Parra, R.
    Sassaki, L. Yukie
    de Mello, M. K.
    Luporini, R. L.
    Chebli, L. A.
    Nobrega, F. J. Firmino
    da Silva, B. C.
    Dutra, R. D. M.
    Vasconcelos, J. R. de Oliveira
    Sales, M. P. Moraes
    Feres, O.
    Parente, J. M. L.
    Troncon, L. E. D. A.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1087 - I1088
  • [50] EFFECTIVENESS OF VEDOLIZUMAB IN THE REAL-WORLD PRACTICE: A REGIONAL EXPERIENCE
    Bodini, G.
    Romana, C.
    Lupo, S.
    Russo, G.
    Dulbecco, P.
    Romagnoli, P.
    Savarese, M. F.
    Caserta, L.
    DIGESTIVE AND LIVER DISEASE, 2018, 50 (02) : E204 - E204
12345